| | Development of a French Isometric Strength Normative Database for Adults Using Quantitative Muscle TestingAbstract Hogrel J-Y, Payan CA, Ollivier G, Tanant V, Attarian S, Couillandre A, Dupeyron A, Lacomblez L, Doppler V, Meininger V, Tranchant C, Pouget J, Desnuelle C. Development of a French isometric strength normative database for adults using quantitative muscle testing. ObjectiveTo establish a normative database for isometric strength measured by quantitative muscle testing (QMT) for a French adult population. DesignMeasurement of maximal voluntary isometric contraction. SettingFour clinical centers involved in neuromuscular disorders. ParticipantsA total of 315 healthy adults (147 men, 168 women) ages 20 to 80 years. InterventionsNot applicable. Main Outcome MeasureIsometric torque values of 14 muscle functions (13 bilaterally and neck). ResultsThis study led to the development of a French isometric strength normative database for adults measured by QMT. For each muscle function, predictive regression models using age, sex, and weight are proposed. Some methodologic issues concerning strength measurement are discussed. ConclusionsThis database can be used to compute relative deficits in muscle strength for 27 muscle functions and also to estimate composite scores for follow-up of patients either during the natural history of their disease or during a therapeutic trial. ANY PATHOLOGY INVOLVING the neuromuscular system can be longitudinally investigated with 1 or several methods to follow degenerative effects on muscle strength during the natural history of the disease or to detect small changes during a therapeutic trial. As already described,1, 2 several methods may be used to assess muscle strength. Depending on the aim of the assessment, each presents several advantages and drawbacks. Methodologic issues are fundamental because patients present with different motor capacities, changes in strength may be fairly small over the duration of the trial, and different evaluators may be involved in different clinical centers. The term quantitative muscle testing (QMT) implies that quantification of strength is performed by a measurement device or sensor.3 It can be performed by handheld dynamometers, strain gauges with 1 extremity fixed to a wall-mounted frame, or isokinetic ergometers. Strain gauges have been frequently used in clinical trials concerning various neuromuscular diseases.4, 5, 6, 7, 8 Strength measurements are performed in isometric conditions to assess the maximal voluntary isometric contraction (MVIC) at a given position. Although muscles produce linear forces, motions at joints are generally rotary. Strength generated around joints should be measured as torque (in newton meters) because the degrees of freedom of joints are mainly rotational. When strength estimates are made, the moment arm must be carefully measured. Otherwise, the reproducibility of measurements cannot be assessed even when anatomic reference marks are methodically respected. According to Munsat,9 MVIC measurement provides a “direct, reproducible, sensitive and practical” method to assess changes in the voluntary motor system. The reliability of QMT was questioned in a report on a multicenter trial in amyotrophic lateral sclerosis (ALS).10 The authors10 argued that the development of precise procedures understood and applied by all the involved evaluators is a prerequisite to achieve consistent measurements. However, compared with manual muscle testing (MMT), which can require multiple training sessions to obtain acceptable reliability, a high level of agreement can be obtained with a single session of training in QMT.11 Andres et al4, 12 developed standardized quantified tests known as the Tufts Quantitative Neuromuscular Exam (TQNE) for evaluating patients suffering from ALS. The TQNE includes measurements of pulmonary and oropharyngeal functions, timed motor activities, and QMT. The different measurements can be combined by using z scores based on the population mean and standard deviation to produce megascores. The TQNE was used for instance by Munsat13 and Conradi14 and colleagues to assess motor disability and disease progression in ALS patients. More recently, MVIC was used in children suffering from Duchenne muscular dystrophy to assess the efficacy of creatine or glutamine supplementation by using QMT and MMT.8 QMT was found to be more sensitive than MMT in detecting muscle loss of strength. Because the range of strength differs between the different muscle functions tested, the computation of composite scores requires the use of predictive models to express data in relative terms such as by z scores or as percentages of predicted values. In 1996, The National Isometric Muscle Strength Database Consortium established a normative database for the population of the United States in 493 adult healthy subjects by using 10 muscle groups.15 Separately, Tawil et al16 computed a regression model on the elbow flexion strength of 32 healthy subjects by using the variables age, sex, and height to show the possibility of computing composite scores (z scores) for the assessment of the strength of patients suffering from facioscapulohumeral dystrophy (FSHD). This first normative database was enlarged to 168 healthy subjects.17 Personius et al18 used these models for an FSHD natural history study. Recently, Meldrum et al19 published median and percentile predicted MVIC values for 9 muscle groups according to age and sex by using quantile regressions based on a sample of 494 healthy subjects in Ireland. It is, thus, possible to locate individual values for a given patient within or under the predicted range. However, the calculation of composite scores, which can be useful as outcome measures in the assessment of therapeutic interventions, is not possible. The main objectives of this study were to establish a normative database for isometric strength measured by QMT for the French population and to propose regression models for clinical use for a larger number of muscle functions to assess patients’ weakness on follow-up. Intra- and interrater reproducibility was also questioned. Methods  Sites Four clinical centers treating patients with neuromuscular disorders participated in the study. The centers were chosen because of their involvement in clinical trials and expertise in neuromuscular disorders. Participants The study involved 315 healthy men (n=147) and women (n=168) aged 20 to 80 years who able to understand and perform the testing procedures. Subjects were uniformly distributed according to age. Exclusion criteria included muscle pathology; inflammatory disease or any disease involving joints; cardiovascular, pulmonary, or metabolic disease; use of regular medication over the past month (except oral contraceptives and hormone replacement therapy); or use of analgesic, anti-inflammatory, or sedative medication over the 2 days before testing and athletes involved in international sports competitions. Inclusion and exclusion criteria were verified through thorough interview and clinical examination by 1 of the medical investigators. Subjects were recruited from hospital personnel, relatives, patient families; advertisements placed in hospitals; or publications of patient associations. All the subjects signed an informed consent form before taking part in the study. The ethics committee of Nice, France, approved the study. Instrumentation All centers used the same QMT system. Such systems are designed to measure muscle-force production during isometric contraction. The system included the following items: a wall-mounted frame,a a load cell that used strain-gauge technology for measuring force,b straps to attach the load cell to the frame and to the patient,c a mobile examination table,d a grip dynamometer,e and a computer for feedback and recording usingQuantitative Muscle Assessment (QMA) software.f Strength signals were sampled at 30Hz and recorded for further analysis. Experimental Procedure We performed strength measurements for 14 muscle functions (13 bilaterally and neck flexion). Patients were placed on the mobile examining table. Wall-mounted traction bars were used to stabilize the pull straps attached to the strain gauge. Testing positions were standardized (table 1). The examiner provided appropriate stabilizations for maximal efforts of each function tested. QMT was performed bilaterally on the individual muscle listed groups. Each subject completed a series of 3 trials in which he/she was asked to produce a maximal voluntary contraction lasting 2 to 4 seconds. The subject was verbally encouraged. A 30-second rest period was allowed between each trial. If at least 2 trials differed by 10% or more, a further trial was performed. MVIC was taken as the maximum value of the trials. Test order was standardized as indicated in the second column of table 2. QMT was performed by recording force (in kilograms) through a direct computer interface linked to the strain gauge. The whole testing examination lasted 90 minutes on average. | | |  | Muscle Function | Patient Position | Strap Position | Stabilization by Tester | Compensation to Avoid |  |
|---|
 | Shoulder abduction | Supine Shoulder at 90° abduction Forearm in neutral position Elbow at 90° | Proximal to elbow above olecranon | Both hands over the acromion | Shoulder flexion and/or rotation |  |  | Shoulder flexion | Prone Shoulder at 90° flexion Elbow in extension Forearm in neutral position | Proximal to elbow above olecranon | Hand over the trapezius muscle | Shoulder abduction or adduction |  |  | Shoulder extension | Prone Shoulder at 90° flexion Elbow in full extension Forearm in neutral position | Proximal to elbow above olecranon | Hand over the trapezius muscle and contralateral forearm on the pelvis | Shoulder abduction or adduction |  |  | Shoulder internal rotation | Prone Shoulder at 90° abduction and neutral rotation Elbow at 90° flexion Forearm hanging down in neutral position | At wrist | Both hands on either side over the distal part of humerus | Shoulder abduction |  |  | Shoulder external rotation | Prone Shoulder at 90° of abduction and neutral rotation Elbow at 90° flexion Forearm hanging down in neutral position | At wrist | Both hands on either side over the distal part of humerus | Shoulder abduction |  |  | Elbow flexion | Supine Elbow at side at 90° flexion Forearm in neutral position | At wrist | One hand on anterior shoulder, other hand on lateral condyles of elbow | Shoulder flexion and/or rotation |  |  | Elbow extension | Supine Elbow at side at 90° flexion Forearm in neutral position | At wrist | One hand on anterior shoulder, other hand on lateral condyles of elbow | Shoulder extension, abduction and/or rotation |  |  | Hip flexion | Supine Hip at 90° flexion Knee at 90° flexion | Proximal to knee | One hand supporting the leg, the other hand on the ASIS | Pelvis swing |  |  | Hip extension | Supine Hip at 90° flexion Knee at 90° flexion | Proximal to knee | One hand supporting the leg, the other hand on the ASIS | Pelvis swing |  |  | Ankle flexion | Supine Hip at full extension Heel raised calf on a cushion | Around metatarsals | One hand proximal to ankle, the other above the knee | Hip or knee flexion |  |  | Knee flexion | Sitting Hip and knee at 90° flexion Thigh on a cushion | At ankle, proximal to malleolus | Examiner seated behind subject Both hands on shoulders | Hip external rotation |  |  | Knee extension | Sitting Hip and knee at 90° flexion Thigh on a cushion | At ankle, proximal to malleolus | Examiner seated behind subject One hand on homolateral shoulder; the other on the contralateral hip | Hip flexion |  |  | Neck flexion | Supine Head on a cushion Arms alongside | Under the chin, around cheeks | None | Avoid full cervical spine flexion |  |  | Handgrip | Sitting Elbow alongside at 90° flexion Forearm and wrist in neutral position | Handgrip width adapted to hand size | Support forearm (not the wrist) Support the upper extremity of the ergometer | Shoulder abduction, internal rotation or flexion Wrist and elbow flexion |  | | | |
| | |  | Muscle Group | Test Order | Men (n=122) | Women (n=140) |  |
|---|
 | Shoulder | | | |  |  | Abduction right | 1 | 51.3±17.7 | 28.4±7.5 |  |  | Abduction left | 4 | 50.1±17.4 | 26.3±7.5 |  |  | Flexion right | 19 | 55.0±17.6 | 30.4±8.7 |  |  | Flexion left | 23 | 52.9±17.8 | 28.7±9.0 |  |  | Extension right | 20 | 73.5±27.9 | 34.3±11.2 |  |  | Extension left | 24 | 71.1±26.6 | 33.4±10.5 |  |  | Internal rotation right | 21 | 41.1±10.1 | 19.4±4.6 |  |  | Internal rotation left | 25 | 40.8±10.0 | 18.7±5.0 |  |  | External rotation right | 18 | 38.3±9.1 | 20.7±5.2 |  |  | External rotation left | 22 | 36.4±8.8 | 19.3±4.4 |  |  | Elbow | | | |  |  | Flexion right | 2 | 70.9±15.9 | 39.4±7.7 |  |  | Flexion left | 5 | 68.5±14.1 | 38.5±7.9 |  |  | Extension right | 3 | 44.3±9.8 | 22.0±4.7 |  |  | Extension left | 6 | 43.9±10.0 | 21.3±4.8 |  |  | Hip | | | |  |  | Flexion right | 10 | 97.4±24.8 | 62.0±17.1 |  |  | Flexion left | 9 | 101.9±26.7 | 63.9±16.7 |  |  | Extension right | 7 | 194.5±70.5 | 116.5±36.5 |  |  | Extension left | 8 | 189.9±64.0 | 121.7±43.2 |  |  | Ankle | | | |  |  | Flexion right | 11 | 38.4±8.6 | 22.9±6.1 |  |  | Flexion left | 12 | 37.7±8.6 | 21.9±5.7 |  |  | Knee | | | |  |  | Flexion right | 14 | 80.6±23.4 | 48.8±15.1 |  |  | Flexion left | 15 | 79.7±21.5 | 48.4±14.2 |  |  | Extension right | 17 | 168.9±48.3 | 100.9±30.5 |  |  | Extension left | 16 | 164.1±46.6 | 96.2±28.6 |  |  | Neck flexion | 13 | 137.0±38.6 | 93.5±33.6 |  |  | Handgrip right | 26 | 411.3±73.5 | 250.4±54.8 |  |  | Handgrip left | 27 | 398.0±76.5 | 244.3±51.1 |  | | | |
We recorded dominant side, weight (in kilograms) and height (in centimeters) for each subject. Body mass index (BMI) was computed (in kilograms per meter squared) as the ratio between the weight and the height squared. The distance between the rotation axis of the joint and the line of application of force (taken at the center of the strap) was measured. Raters were trained for reliable level arm measurement. When procedures and anatomic references are respected, the relative measurement error was generally less than 5% in our experience, which is lower than the expected intrinsic variability of strength measurements (10%–15% for healthy subjects). The straps were positioned in accordance with anatomic references as given in table 3. The torque was then computed (in newton meters) as the product of the recorded force and this moment arm. | | |  | Function | Reference |  |
|---|
 | Shoulder abduction, flexion, and extension | Acromial process |  |  | Shoulder external and internal rotation | Lateral humeral epicondyle |  |  | Elbow flexion and extension | |  |  | Hip extension and flexion | Greater trochanter |  |  | Ankle flexion | Lateral malleolus |  |  | Knee extension and flexion | Lateral knee joint |  | | | |
Reliability Study of Testing Procedures Before the study, all examiners attended a training session. A reliability study was performed to assess intra- and interrater reliability and validate the procedure of testing established during training. Ten subjects participated in an intrarater reliability tests involving 4 physiotherapists, and 10 subjects participated in an interrater reliability study involving 6 physiotherapists. QMT was performed twice at a maximum interval of 1 week. Data Analysis Strength values are given as torque in newton meters. Analysis of variance (ANOVA) was performed to analyze differences between centers. To take into account the number of comparisons, P-level significance was adjusted according to the Bonferroni procedure. Reliability results (inter- and intrarater agreement coefficients for each muscle group) are expressed as intraclass coefficients (ICCs) computed with a random-effects ANOVA model. To study the relation of strength with the following covariates: age, sex, height, weight, and BMI, stepwise multiple linear regressions were performed to identify significant parameters. The most common significant parameters found for the 27 muscle groups were age, sex, and weight. These covariates were, therefore, retained to calculate regression parameters for each muscle group by using multiple linear regressions. Ninety-five percent prediction intervals were calculated as the muscle strength value ± the square root of the mean square error. Statistical analysis was performed by using BMDP software.g Results  Between-Center Variability Despite precise measurement procedures and careful evaluator training, ANOVA revealed a significant center effect on torque estimates (P<.001) for 13 of 27 muscle functions. These differences were because 1 center reported lower values, even after adjusting for age, sex, and weight (although there were no differences between centers for these parameters). After close examination of the data and a complementary study examining how the different examiners followed the measurement procedures, we decided to exclude this center for further analysis. When data were reanalyzed without the excluded center, 3 muscle functions still presented a significant difference between the remaining centers: shoulder abduction and hip flexion and extension. The standard errors of the predicted models were not significantly increased by reducing the number of subjects (53/315). Strength Value in a Referent Population Data from the 3 remaining centers were pooled. Two hundred sixty-two subjects were finally analyzed. Their characteristics are given in table 4. Mean strength values ± standard deviation (SD) are given in table 2. The right side was dominant for 86% of the subjects. The dominant side was significantly stronger than the nondominant side (P<.05) for all functions except hip flexion and extension, knee flexion, and shoulder internal rotation, for which strength was similar for both sides (not shown). | | |  | Subjects | N | Age (y) | Weight (kg) | Height (cm) | BMI (kg/m2) |  |
|---|
 | Men | 122 | 43.6±15.8 | 78.0±11.4 | 176±7 | 25.1±3.2 |  |  | Women | 140 | 46.5±17.1 | 61.4±10.3 | 164±7 | 22.9±3.3 |  |  | Total | 262 | 45.1±16.5 | 69.2±13.6 | 170±9 | 23.9±3.5 |  | | | |
Regression parameters of the covariates age, sex, and weight are listed in table 5 for each muscle group. Height was not considered in the regression model because this parameter was nonsignificant in the model for most of the muscle functions. All regression models were significant at P less than .001. Using these equations, it was possible to compute for a patient of any age, sex, and weight a predicted strength value for each muscle group and, hence, a relative deficit with respect to a normative value. It was also possible to standardize the measurements using z scores, as used for example by Tawil et al,16 according to the following equation: Such scores give a quantified “distance” from normative data in number of SDs with respect to the average referent performance. It was then possible to compute composite scores for the whole body and for the upper and lower limbs. The mean of z scores was calculated, taking as a rule that in cases of missing data (eg, because of pain or retractions), it was necessary to have at least half the functions available to compute the composite score. An illustration of the usefulness of these calculations is appended in an attached case study. | | |  | Muscle Group | N | Intercept | Age | Sex | Weight | R | SD |  |
|---|
 | Shoulder | | | | | | | |  |  | Abduction right | 252 | 7.93 | −0.19 | 14.30 | 0.48 | .73 | 11.98 |  |  | Abduction left | 259 | 12.43 | −0.16 | 17.53 | 0.35 | .72 | 12.33 |  |  | Flexion right | 258 | 9.02 | −0.16 | 16.35 | 0.47 | .74 | 12.41 |  |  | Flexion left | 259 | 11.07 | −0.21 | 16.15 | 0.45 | .73 | 12.55 |  |  | Extension right | 260 | 14.52 | −0.26 | 29.80 | 0.52 | .73 | 19.63 |  |  | Extension left | 261 | 15.89 | −0.29 | 28.69 | 0.50 | .74 | 18.42 |  |  | Internal rotation right | 258 | 10.20 | −0.13 | 17.19 | 0.25 | .86 | 6.85 |  |  | Internal rotation left | 259 | 11.44 | −0.16 | 17.76 | 0.24 | .86 | 6.87 |  |  | External rotation right | 255 | 7.64 | −0.07 | 13.03 | 0.26 | .82 | 6.62 |  |  | External rotation left | 250 | 9.70 | −0.08 | 13.28 | 0.22 | .82 | 6.31 |  |  | Elbow | | | | | | | |  |  | Flexion right | 260 | 18.20 | −0.19 | 22.72 | 0.49 | .85 | 10.65 |  |  | Flexion left | 261 | 22.00 | −0.16 | 23.17 | 0.39 | .84 | 10.12 |  |  | Extension right | 258 | 9.31 | −0.12 | 16.94 | 0.30 | .86 | 6.51 |  |  | Extension left | 259 | 8.79 | −0.10 | 17.69 | 0.28 | .87 | 6.89 |  |  | Hip | | | | | | | |  |  | Flexion right | 257 | 35.86 | −0.29 | 23.80 | 0.64 | .71 | 19.36 |  |  | Flexion left | 260 | 38.65 | −0.29 | 26.37 | 0.64 | .71 | 20.39 |  |  | Extension right | 255 | 23.56 | −0.21 | 49.10 | 1.68 | .64 | 52.18 |  |  | Extension left | 256 | 24.58 | −0.17 | 39.77 | 1.71 | .61 | 50.67 |  |  | Ankle | | | | | | | |  |  | Flexion right | 257 | 11.65 | −0.04 | 11.97 | 0.21 | .75 | 7.20 |  |  | Flexion left | 256 | 10.55 | −0.08 | 11.42 | 0.24 | .79 | 6.61 |  |  | Knee | | | | | | | |  |  | Flexion right | 261 | 36.81 | −0.49 | 20.85 | 0.57 | .75 | 16.63 |  |  | Flexion left | 259 | 36.28 | −0.42 | 21.46 | 0.51 | .75 | 15.72 |  |  | Extension right | 258 | 66.37 | −0.87 | 46.09 | 1.21 | .75 | 35.05 |  |  | Extension left | 259 | 78.00 | −0.87 | 49.70 | 0.96 | .75 | 33.93 |  |  | Neck flexion | 257 | 110.35 | −0.86 | 34.77 | 0.38 | .63 | 32.91 |  |  | Handgrip right | 261 | 225.17 | −1.22 | 134.93 | 1.34 | .82 | 59.57 |  |  | Handgrip left | 258 | 211.93 | −1.26 | 124.96 | 1.49 | .81 | 58.88 |  | | | |
We compared our data with published normative data on the U.S. population.15 On the whole, the strength measurements yield significant higher values for the American population except for hip extension, which was significantly higher for the French population. We computed the predicted strength for each muscle function in our study population with both regression equations from the American study and the present one. The French strength predictions were 10% lower on average compared with the U.S. predictions. The differences varied from −50% to 26% depending on the muscle function. The less comparable functions were hip (about −50% for flexion and 26% for extension), shoulder (about −15% for flexion and −17% for extension), and elbow extension (about −19%). The other functions gave smaller differences (close to ±5%). The ratio between right and left sides were higher when using the U.S. prediction models than the French ones. Discussion  Usefulness of a Normative Database This study involved the development of a French isometric strength normative database for adults measured by using QMT. This will allow objective evaluation of patients with respect to these normative data, assessment of the degree of their neuromuscular deterioration, and collection of information on the clinical course of the disease. Using relative changes is not the same as using z scores. Indeed, for weak forces, a small change would lead to a strong relative change but only to a minor z-score change. Moreover, the use of z scores allows the patient to be situated with respect to normative values and reveals the profile of the deficit. For example, consider a patient presenting with a torque value for ankle flexion of 1.02Nm increasing to 2.42Nm 6 months later. This change corresponds to a variation of 137%. If the same values are expressed as z scores, the variation is only 4%. A normative database also allows the computation of composite scores, which may be more robust and more sensitive than isolated muscle functions in the assessment of global improvements of patients involved in a therapeutic trial. As shown in the case study presented earlier, the analysis of individual muscle functions was insufficient for the overall evaluation of strength progression, which became possible by looking at the composite scores (see fig 1). Direct computation of composite scores from raw data is not valid because muscle strengths of different magnitudes measured around joints with different mechanical properties are not summative.17 This is still less valid in the follow-up of patients because different muscle functions can change inhomogeneously during a therapeutic trial. We have also designed this protocol to get specific functions that have not been assessed yet in previous publications, such as shoulder internal and external rotation and neck flexion, which were required for use in a therapeutic trial in FSHD involving significant shoulder impairment. Comparing our strength values with the American ones,15 significantly lower values were observed for our population, apart from hip extension. The predictive values deduced from our regression models were also lower than the predictive values computed from the American predictive regression models. The differences observed could have several origins such as the morphology of the subjects and the variables used in the models. The analyses in several studies on normative strength show a marked variation depending on the country, which can be partly explained by differences in methodologic procedures. However, differences could also be caused by morphologic, anatomic, ethnic, cultural, and social characteristics of the healthy populations that have been involved in such protocols. Interestingly, our strength values were slightly higher than or similar to ones presented by Meldrum et al19 for the Irish population. When assessing strength around a joint, the measurement of force alone is not sufficient to provide a good estimate of muscle strength because it also depends on the lever arm. For example, a measurement error of 2cm on a lever arm measuring 20cm gives rise to an error of 10% in the force. It is, thus, essential to record measurement of strength as torque and to use the corresponding predictive regression models to give consistent comparisons between individuals. This point is particularly crucial when children are involved in the protocols.20 Methodologic Issues The factors leading to variability in strength measurement are numerous and can be classified as technical, methodologic, environmental, and human factors.21 This study involved 4 centers and 10 clinical evaluators, increasing the risks of measurement variability. For each protocol, functions to be evaluated should be carefully determined according to the disease, taking into account fatigue of patients, especially if other tests are also required. The time of day of testing must be defined. A learning session should also be organized before the trial (eg, during prescreening) so that patients can get familiar with the apparatus and procedures and initiate a relationship of confidence with the evaluator. Evaluation procedures must be described precisely to prevent more than 1 possible interpretation of the measurement process. In our protocol, the modus operandi was defined for positioning, installing, and stabilizing the subject and the strap. It was stipulated that the evaluators maintain the position of subject, even with straps, to avoid any compensation. In 1 center, this was not done systematically because the evaluator was not strong enough to stabilize the strongest subjects, resulting in lower estimates of MVIC. Stabilization methods are a critical concern for strong subjects and may be inefficient or inadequate. This issue has been discussed in some studies for particular functions such as hip extension,22 but this is likely to be true for any strong muscle function. When the aim is to assess the MVIC, it does not seem consistent to ask the subjects to stabilize for themselves the position of their body segments because the maximal force cannot be attained. However, it may be more reproducible to ask the subjects to stabilize themselves when they are strong. In general, measurement procedures should be adapted to the aim of the study and the populations involved. If a source of error is detected during a clinical trial, such as modifications in stabilization procedures or relative body part positions, it should not be addressed during the protocol but should be addressed in subsequent trials. When assessing torques, lever arms must be precisely measured in the testing position because the joint rotation axis may move with respect to its position. This is, for instance, the case for shoulder abduction for which we observed a center effect probably related to various measurement procedures of the lever arm. This is also why precise anatomic landmarks must be defined and documented for each testing position. When repeated evaluations are planned during a trial, it is highly recommended that each patient should be tested by the same examiner. Also, in a multicenter trial, repeated training sessions with all examiners should be organized at regular intervals (every 3 or 6mo). The QMA software itself retains the highest value recorded on the force transducer during the effort. However, this maximal value can be situated on an overshoot or an artifact, which leads to an overestimation of the patients’ observed MVIC. Evaluators must make sure that such a situation does not occur. Missing data can be a problem when computing megascores. Different situations can be responsible such as pain, retractions, or fatigue. If missing data are clearly caused by major impairment, the function should be recorded as 0. If other reasons apply, it is reasonable to compute the mean of the z scores if more than half the planned functions could be evaluated. However, simulations by bootstrapping have shown that scores computed from incomplete dataset are highly correlated with scores computed on complete datasets (R>0.9). This last observation is true only for healthy subjects as considered in the current study and is, however, certainly not true for patients because the composite score can be greatly biased depending on which functions on which sides are lacking. This issue deserves further work. Predictive Strength Reliability We have proposed for each muscle function a predictive regression model performed using age, sex, and weight as also recently proposed for children by Eek et al.20 In other predictive models, other variables were used instead of weight such as BMI15 or height.16, 17 In our study, height was not a significant predictor variable for most muscle functions. Although age, sex, and weight were significant for strength expressed either in kilograms or newton meters for most of the muscle functions tested, height was significant for only 3 of 27 functions when strength was expressed in kilograms and for 8 functions when strength was expressed in newton meters. We also tested the significance of BMI to explain muscle strength. In most cases (19/27 functions when strength was expressed in kilograms and 22/27 when strength was expressed in newton meters), this variable was not a significant predictor of strength. Moreover, as assessed by stepwise regression, height and BMI were less predictive variables with respect to age, sex, and weight. The regression coefficients were similar to previous studies with adults.15 These predictive regression models make it possible to assess the relative weakness of patients. Reproducibility Issues Although performed on few subjects and for few repeated measurements, our results concerning reproducibility are good to excellent for most of the muscle functions tested, in agreement with previous studies.11 This good reliability underlines that the learning effect in healthy adults tested by trained raters is minor.8, 22 Only with standardized operated procedures and repeated training sessions can satisfactory reproducibility be attained. Conclusions  This study has led to the development of an isometric strength normative database for French adults by using QMT. The database will be used to compute composite scores in therapeutic trials to follow a global index of strength. No consensus exists on the various methods to use for strength measurement.23, 24, 25 No method is perfect or ideal yet, and none will probably ever be. The challenge is to provide each clinical trial with appropriate, standardized, reliable and sensitive outcome measurements. Because therapeutic trials may concern rare disorders, multiple centers are often involved to reach the statistical power required to show treatment efficacy. Thus, it is fundamental that all centers use the same methodologic procedures to assess outcome measure such as strength. Rigorous training and monitoring are required before and during any therapeutic trial so as not to compromise the quality of its results. Suppliers Acknowledgment  We are grateful to Denis De Castro, MD, for his kind assistance in the language revision of the manuscript. References  1. 1Cook JD, Glass DS. Strength evaluation in neuromuscular disease. Neurol Clin. 1987;5:101–123. MEDLINE 2. 2Andres P, Skerry L, Munsat T. Measurement of strength in neuromuscular diseases. In: Munsat T editors. Quantification of neurologic deficit. Stoneham: Butterworth; 1989;p. 87–100. 3. 3Edwards RH. Quantitative methods of assessing skeletal muscle function for therapeutic trials. Acta Cardiomiol III. 1991;2:185–198. 4. 4Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology. 1986;36:937–941. MEDLINE 5. 5Iannaccone ST, Hynan LSAmerican Spinal Muscular Atrophy Randomized Trial (AmSMART) Group. Reliability of 4 outcome measures in pediatric spinal muscular atrophy. Arch Neurol. 2003;60:1130–1136. MEDLINE |
CrossRef
6. 6Kissel JT, McDermott MP, Mendell JR, et al.FSH-DY Group Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology. 2001;57:1434–1440. MEDLINE 7. 7van der Kooi EL, Vogels OJ, van Asseldonk RJ, et al. Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology. 2004;63:702–708. 8. 8Escolar DM, Buyse G, Henricson E, et al.CINRG Group CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann Neurol. 2005;58:151–155. MEDLINE |
CrossRef
9. 9Munsat TL. Development of measurement techniques. Neurology. 1996;47:S83–S85. MEDLINE 10. 10Hoagland RJ, Mendoza M, Armon C, et al. Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis (Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study Group). Muscle Nerve. 1997;20:691–695.
CrossRef
11. 11Mayhew JE, Florence JM, Mayhew TP, et al. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. Muscle Nerve. 2007;35:36–42.
CrossRef
12. 12Andres PL, Finison LJ, Conlon T, Thibodeau LM, Munsat TL. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis. Neurology. 1988;38:405–408. MEDLINE 13. 13Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau L. The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology. 1988;38:409–413. MEDLINE 14. 14Conradi S, Ronnevi LO. Pitfalls in the evaluation of isometric strength (TQNE) data in ALS. J Neurol Sci. 1996;139(Suppl):60–63. |
CrossRef
15. 15The National Isometric Muscle Strength (NIMS) Database Consortium. Muscular weakness assessment use of normal isometric strength data. Arch Phys Med Rehabil. 1996;77:1251–1255. Abstract |
Full-Text PDF (717 KB)
16. 16Tawil R, McDermott MP, Mendell JR, Kissel J, Griggs RC. Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing (FSH-DY Group). Neurology. 1994;44:442–446. MEDLINE 17. 17The FSH-DY Group. A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. Neurology. 1997;48:38–46. MEDLINE 18. 18Personius KE, Pandya S, King WM, Tawil R, McDermott MP. Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements (The FSH DY Group). Phys Ther. 1994;74:253–263. MEDLINE 19. 19Meldrum D, Cahalane E, Conroy R, Fitzgerald D, Hardiman O. Maximum voluntary isometric contraction: reference values and clinical application. Amyotroph Lateral Scler. 2007;8:47–55. MEDLINE |
CrossRef
20. 20Eek MN, Kroksmark AK, Beckung E. Isometric muscle torque in children 5 to 15 years of age: normative data. Arch Phys Med Rehabil. 2006;87:1091–1099. Abstract | Full Text |
Full-Text PDF (286 KB)
|
CrossRef
21. 21Hogrel JY, Ollivier G, Desnuelle C. [Manual and quantitative muscle testing in neuromuscular disorders (How to assess the consistency of strength measurements in clinical trials?). Rev Neurol (Paris). 2006;162:427–436. MEDLINE 22. 22Meldrum D, Cahalane E, Keogan F, Hardiman O. Maximum voluntary isometric contraction: investigation of reliability and learning effect. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:36–44. MEDLINE |
CrossRef
23. 23Sanjak M. Measurement of strength: pro. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3(Suppl 1):S45–S47. 24. 24Sorenson E. Measurement of strength: con. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3(Suppl 1):S49–S50. 25. 25Miller RG. Measurement of strength: summary. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3(Suppl 1):S51–S54. a Institut de Myologie, GH Pitié-Salpêtrière, Paris, France b Département de Pharmacologie Clinique, GH Pitié-Salpêtrière, Paris, France c Fédération des Maladies du Système Nerveux, GH Pitié-Salpêtrière, Paris, France d Centre de Référence Maladies Neuromusculaires, Hôpital de l’Archet, Nice, France e Service de Neurologie, CHU La Timone, Marseille, France f Service de Neurologie, CHU de Strasbourg, Strasbourg, France. Reprint requests to Jean-Yves Hogrel, PhD, Institut de Myologie, GH Pitié-Salpêtrière, 75651 Paris Cedex 13, France
Supported by the Association de Recherche sur la Sclérose Latérale Amyotrophique and the Association Française contre les Myopathies. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated. PII: S0003-9993(07)01282-8 doi:10.1016/j.apmr.2007.07.011 © 2007 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved. | |
|